Newsfeeds Archive - Page 44 of 56

2 minute read

LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress

November 4, 2:57 PM

Holding company Blackhawk Growth Corp.(OTC: BLRZF)'s subsidiary company MindBio Therapeutics Pty Ltd shared the positive data gathered from its

BLRZF

2 minute read

Oregon’s Jackson County Hosts Hearing On Amendments For Psilocybin Services Centers, ‘Opt-Out’ Vote

By Lara Goldstein

November 4, 12:53 PM

“Never a dull moment in the psychedelics space,” says Silo Wellness (OTCQB: SILFF) founder and CEO Mike Arnold.

SILFF

2 minute read

Legal Mushroom Products From Amanita Muscaria Shipped To 37 US States

By Lara Goldstein

November 3, 7:37 PM

Canadian-based producer of mushroom-derived health supplements Psyched Wellness Ltd.

PSYCF

2 minute read

Florida’s Growing Psychedelic Treatment Options: Healthcare Company Expands Network Of Clinics

By Lara Goldstein

November 3, 2:37 PM

Senior health brand Irwin Naturals Inc.

IWINF

3 minute read

Psychedelic Therapy Frontiers Podcast Is Back, Check Out Upcoming Episodes

By Lara Goldstein

November 1, 5:13 PM

Mental health care company Numinus Wellness (OTCQX: NUMIF) is re-launching its "Psychedelic Therapy Frontiers" podcast series dedicated to exploring the psychedelics renaissance and cultivating mind, body and spiritual health with new hosts, expanded topics and fr

NUMIF

3 minute read

Ketamine Therapy: Revitalist’s New Financing Option, Irwin Naturals Expands Chain Of Clinics

By Lara Goldstein

November 1, 2:19 PM

Revitalist Increases Patient Access By Financing Costs With M-Lend Financial

IWINF

4 minute read

Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant’s LSD Therapy & More

By Lara Goldstein

November 1, 10:46 AM

15 Global Psychedelics Executives To Keep An Eye On In 2022

KONEF

5 minute read

EXCLUSIVE: Insider’s Peek At Mammoth Of Psychedelics VCs, Palo Santo’s Investment Fundamentals & Specificities

By Lara Goldstein

October 31, 2:37 PM

(Part one of a four-part series)

ATAI

4 minute read

Australian Psychedelics: Incannex Business & Financials, New Research Center For Mushrooms & Eating Disorders

By Lara Goldstein

October 28, 6:38 PM

Clinical-stage biopharma company Incannex Healthcare Ltd. (NASDAQ: IXHL) shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several U.S.

IXHL

2 minute read

Mental Health Provider Expands Psychedelic-Assisted Therapy For Chronic & Serious Medical Illnesses

By Lara Goldstein

October 28, 2:28 PM

Numinus Wellness Inc. (OTCQX: NUMIF) announced the launch of its new clinical program, ketamine for chronic and serious medical illness, to be first introduced at Utah, BC and Quebec clinics and then expanded to Numinus' remaining facilities.

NUMIF